As of my last update in January 2022, Tucaxen (tucatinib) is a medication used in the treatment of HER2-positive breast cancer, particularly in cases where the cancer has metastasized or spread to other parts of the body. While Tucaxen is generally well-tolerated by many patients, there are specific populations for whom its use may be contraindicated or require special consideration.
Hypersensitivity: Individuals with a known hypersensitivity or allergic reaction to Tucaxen 150 mg (Tucatinib) or ...